carbonthatcarbonthat
← Every company

Praxis Precision Medicines Inc Insider Trading

Every director, officer and 10% holder of Praxis Precision Medicines Inc has to report each trade in its stock within two business days of making it. This is those filings.

PRAX on carbonthat →
Insiders filing
1
2 reported lines
Open-market buys
0
Open-market sales
0
Net
—
bought more

Purchases and sales

Open-market trades only — the lines where someone chose to buy or sell at the going price.

No open-market trades

Every line on file for this company is compensation rather than a decision. Show everything to see them.

Source: SEC Form 4 filings, via EDGAR. A derivative line reports the shares underlying an option rather than stock outstanding, so it is marked and is not comparable with the rest. Value is shares times the reported price, and is blank where the filing priced the transaction at zero — a grant costs its recipient nothing. Insiders sell for reasons that have nothing to do with the company, which is why a sale is not read as a signal on its own.

More on PRAX

Company overviewEverything on PRAX in one place, with the price.SEC filingsWhat PRAX's 8-Ks say happened: results, departures, auditor changes.Executive payWhat PRAX awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in PRAX.Funds holding itWhich funds and ETFs hold PRAX, and how big a bet.LobbyingWhat PRAX spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on PRAX's account, and who they worked for.PatentsWhat PRAX is filing at the patent office.

Follow Praxis Precision Medicines Inc (PRAX) by email

New trades in Praxis Precision Medicines Inc (PRAX) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.

Unsubscribe with one click from any email.

Related datasets

PeopleCEOs, investors, public officials and market commentators.SEC FilingsAuditor changes, restatements, departures and results, from 8-Ks.Insider BuyingCluster buys, and chief executives buying their own stock.The InsidersOne page per filer: every company they file against.